Bystander hyperactivation of preimmune CD8+ T cells in chronic HCV patients.

Archive ouverte

Alanio, Cécile | Nicoli, Francesco | Sultanik, Philippe | Flecken, Tobias | Perot, Brieuc | Duffy, Darragh | Bianchi, Elisabetta | Lim, Annick | Clave, Emmanuel | van Buuren, Marit M | Schnuriger, Aurélie | Johnsson, Kerstin | Boussier, Jeremy | Garbarg-Chenon, Antoine | Bousquet, Laurence | Mottez, Estelle | Schumacher, Ton N | Toubert, Antoine | Appay, Victor | Heshmati, Farhad | Thimme, Robert | Pol, Stanislas | Mallet, Vincent | Albert, Matthew L

Edité par CCSD ; eLife Sciences Publication -

International audience. Chronic infection perturbs immune homeostasis. While prior studies have reported dysregulation of effector and memory cells, little is known about the effects on naïve T cell populations. We performed a cross-sectional study of chronic hepatitis C (cHCV) patients using tetramer-associated magnetic enrichment to study antigen-specific inexperienced CD8(+) T cells (i.e., tumor or unrelated virus-specific populations in tumor-free and sero-negative individuals). cHCV showed normal precursor frequencies, but increased proportions of memory-phenotype inexperienced cells, as compared to healthy donors or cured HCV patients. These observations could be explained by low surface expression of CD5, a negative regulator of TCR signaling. Accordingly, we demonstrated TCR hyperactivation and generation of potent CD8(+) T cell responses from the altered T cell repertoire of cHCV patients. In sum, we provide the first evidence that naïve CD8(+) T cells are dysregulated during cHCV infection, and establish a new mechanism of immune perturbation secondary to chronic infection.

Suggestions

Du même auteur

Primary immune responses are negatively impacted by persistent herpesvirus infections in older people: results from an observational study on healthy subjects and a vaccination trial on subjects aged more than 70 years old

Archive ouverte | Nicoli, Francesco | CCSD

International audience. Background: Advanced age is accompanied by a decline of immune functions, which may play a role in increased vulnerability to emerging pathogens and low efficacy of primary vaccinations in el...

Inhibition of DPP4 activity in humans establishes its in vivo role in CXCL10 post‐translational modification: prospective placebo‐controlled clinical studies

Archive ouverte | Decalf, Jérémie | CCSD

International audience. Biochemical experiments, animal models, and observational studies in humans all support a role of dipeptidyl peptidase 4 (DPP4) in the N-terminal truncation of CXCL10, which results in the ge...

Safety of sitagliptin in treatment of hepatocellular carcinoma in chronic liver disease patients

Archive ouverte | Hollande, Clémence | CCSD

International audience. Background & Aims : Systemic therapies for hepatocellular carcinoma (HCC) treatment have limited efficacy and poor safety. Dipeptidyl peptidase-4 inhibitors were initially developed and appro...

Chargement des enrichissements...